bluebird bio, Inc. (BLUE)
NASDAQ: BLUE · Real-Time Price · USD
8.35
+0.09 (1.09%)
Jan 17, 2025, 4:00 PM EST - Market closed
bluebird bio Market Cap
bluebird bio has a market cap or net worth of $81.18 million as of January 21, 2025. Its market cap has decreased by -45.81% in one year.
Market Cap
81.18M
Enterprise Value
385.63M
1-Year Change
-45.81%
Ranking
Category
Stock Price
$8.35
Market Cap Chart
Since June 19, 2013, bluebird bio's market cap has decreased from $588.50M to $81.18M, a decrease of -86.21%. That is a compound annual growth rate of -15.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 81.20M | 0.12% |
| Dec 31, 2024 | 81.10M | -46.26% |
| Dec 29, 2023 | 150.90M | -73.70% |
| Dec 30, 2022 | 573.70M | -18.09% |
| Dec 31, 2021 | 700.40M | -75.61% |
| Dec 31, 2020 | 2.87B | -40.85% |
| Dec 31, 2019 | 4.86B | -10.51% |
| Dec 31, 2018 | 5.43B | -33.53% |
| Dec 29, 2017 | 8.16B | 254.64% |
| Dec 30, 2016 | 2.30B | -2.28% |
| Dec 31, 2015 | 2.36B | -10.90% |
| Dec 31, 2014 | 2.64B | 429.89% |
| Dec 31, 2013 | 498.90M | -15.23% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 341.33B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |